clinicopathological study of women with endometrial hyperplasia
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- maulana azad medical college
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- treatment outcome of women with endometrial hyperplasia after 6 months
Study Overview
Brief Summary
patients visiting LNH OPD with already diagnosed histopathology of endometrial hyperplasia between age group of 35-65 years will be enrolled into the study. they will be given treatment according to the latest RCOG /ACOG guidelines and followed up at 6 weeks and 6 months with symtpoms and histopatholgy as per follow up guidelines. various risk factors that are already established with the risk for endometrial hyperplasia will be studied and association between the type of disease and risk factors will be evaluated.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 35.00 Year(s) to 65.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •all patients visiting the OPD between 35-65 years.
Exclusion Criteria
- •women below 35 years and above 65 years no males.
Outcomes
Primary Outcomes
treatment outcome of women with endometrial hyperplasia after 6 months
Time Frame: at 6 weeks and 6 months
Secondary Outcomes
- association of risk factors to endometrial hyperplasia type(percentage wise type of disease associated with known risk factors)
Investigators
priya mehar
maulana azad medical college
